| James Caswell, MD | |
|
750 E Adams St, Syracuse, NY 13210-2342 | |
| (315) 464-4899 | |
| Not Available |
| Full Name | James Caswell |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 19 Years |
| Location | 750 E Adams St, Syracuse, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033358627 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 33008 (South Carolina) | Primary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hilton Head Regional Medical Center | Hilton head island, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medstream Anesthesia Pllc | 7416198049 | 566 |
News Archive
The World Health Organization (WHO) has confirmed that Australia has managed to eliminate the viral infection rubella from its population. This is a significant achievement on part of the country's healthcare system. WHO defines elimination of a disease as "reduction to zero of the incidence of infection caused by a specific agent in a defined geographical area".
Heart failure with concomitant pulmonary hypertension is a growing health problem with a high mortality rate, above all in older people. The cardiologist Diana Bonderman from the University Department of Internal Medicine II at the MedUni Vienna, as the author of a multinational phase II study, has demonstrated the effectiveness of a substance that sticks to the so-called nitric oxide pathway and makes the heart "softer".
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Quetiapine Fumarate Tablets, 25 mg.
The National Science Foundation has awarded $6 million to researchers in Kentucky, Oklahoma and Rhode Island to develop innovative and broadly accessible brain imaging technologies to provide insight into how the nervous system functions in health and disease.
› Verified 1 days ago
| Entity Name | Lighthouse Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306036561 PECOS PAC ID: 4082702386 Enrollment ID: O20080505000267 |
News Archive
The World Health Organization (WHO) has confirmed that Australia has managed to eliminate the viral infection rubella from its population. This is a significant achievement on part of the country's healthcare system. WHO defines elimination of a disease as "reduction to zero of the incidence of infection caused by a specific agent in a defined geographical area".
Heart failure with concomitant pulmonary hypertension is a growing health problem with a high mortality rate, above all in older people. The cardiologist Diana Bonderman from the University Department of Internal Medicine II at the MedUni Vienna, as the author of a multinational phase II study, has demonstrated the effectiveness of a substance that sticks to the so-called nitric oxide pathway and makes the heart "softer".
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Quetiapine Fumarate Tablets, 25 mg.
The National Science Foundation has awarded $6 million to researchers in Kentucky, Oklahoma and Rhode Island to develop innovative and broadly accessible brain imaging technologies to provide insight into how the nervous system functions in health and disease.
› Verified 1 days ago
| Entity Name | Medstream Anesthesia Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649616160 PECOS PAC ID: 7416198049 Enrollment ID: O20140304001021 |
News Archive
The World Health Organization (WHO) has confirmed that Australia has managed to eliminate the viral infection rubella from its population. This is a significant achievement on part of the country's healthcare system. WHO defines elimination of a disease as "reduction to zero of the incidence of infection caused by a specific agent in a defined geographical area".
Heart failure with concomitant pulmonary hypertension is a growing health problem with a high mortality rate, above all in older people. The cardiologist Diana Bonderman from the University Department of Internal Medicine II at the MedUni Vienna, as the author of a multinational phase II study, has demonstrated the effectiveness of a substance that sticks to the so-called nitric oxide pathway and makes the heart "softer".
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Quetiapine Fumarate Tablets, 25 mg.
The National Science Foundation has awarded $6 million to researchers in Kentucky, Oklahoma and Rhode Island to develop innovative and broadly accessible brain imaging technologies to provide insight into how the nervous system functions in health and disease.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James Caswell, MD Po Box 1123, 255 West Michigan Avenue, Jackson, MI 49204-1123 Ph: (800) 516-5315 | James Caswell, MD 750 E Adams St, Syracuse, NY 13210-2342 Ph: (315) 464-4899 |
News Archive
The World Health Organization (WHO) has confirmed that Australia has managed to eliminate the viral infection rubella from its population. This is a significant achievement on part of the country's healthcare system. WHO defines elimination of a disease as "reduction to zero of the incidence of infection caused by a specific agent in a defined geographical area".
Heart failure with concomitant pulmonary hypertension is a growing health problem with a high mortality rate, above all in older people. The cardiologist Diana Bonderman from the University Department of Internal Medicine II at the MedUni Vienna, as the author of a multinational phase II study, has demonstrated the effectiveness of a substance that sticks to the so-called nitric oxide pathway and makes the heart "softer".
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Quetiapine Fumarate Tablets, 25 mg.
The National Science Foundation has awarded $6 million to researchers in Kentucky, Oklahoma and Rhode Island to develop innovative and broadly accessible brain imaging technologies to provide insight into how the nervous system functions in health and disease.
› Verified 1 days ago
Judith H Benedict, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 736 Irving Ave, Syracuse, NY 13210 Phone: 315-470-7828 Fax: 315-470-5811 | |
Dr. Joan E Thornton, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 301 Prospect Ave, Dept Of Anesthesia, Syracuse, NY 13203 Phone: 315-299-5451 Fax: 315-299-4710 | |
Dr. Mihael J Puc, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 301 Prospect Ave, Department Of Anesthesia, Syracuse, NY 13203 Phone: 315-448-5440 Fax: 315-472-5010 | |
Dr. Michael Hauser, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 750 E Adams St, Syracuse, NY 13210 Phone: 315-464-4720 | |
Fenghua Li, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 750 E Adams St, Syracuse, NY 13210 Phone: 315-464-4720 | |
Dr. Yinan Chen, M.D./PH.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 750 E Adams St, Syracuse, NY 13210 Phone: 315-464-4720 Fax: 315-464-4905 |